New York State Common Retirement Fund Sells 2,000 Shares of Masimo Co. (NASDAQ:MASI)

New York State Common Retirement Fund lessened its holdings in Masimo Co. (NASDAQ:MASI) by 7.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 24,163 shares of the medical equipment provider’s stock after selling 2,000 shares during the period. New York State Common Retirement Fund’s holdings in Masimo were worth $3,994,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of MASI. UMB Bank n.a. boosted its stake in Masimo by 180.9% during the fourth quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 123 shares during the period. Trust Co. of Vermont purchased a new position in Masimo during the fourth quarter worth $33,000. Blue Trust Inc. boosted its stake in Masimo by 56.3% during the fourth quarter. Blue Trust Inc. now owns 197 shares of the medical equipment provider’s stock worth $33,000 after buying an additional 71 shares during the period. GAMMA Investing LLC boosted its stake in Masimo by 136.5% during the fourth quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider’s stock worth $77,000 after buying an additional 269 shares during the period. Finally, Harvest Fund Management Co. Ltd purchased a new position in Masimo during the third quarter worth $118,000. Institutional investors own 85.96% of the company’s stock.

Wall Street Analysts Forecast Growth

MASI has been the subject of several recent analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a research note on Wednesday. Stifel Nicolaus reaffirmed a “buy” rating and set a $190.00 price objective (up from $170.00) on shares of Masimo in a research note on Friday, November 22nd. Raymond James boosted their target price on shares of Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research note on Friday, December 27th. Wells Fargo & Company boosted their target price on shares of Masimo from $193.00 to $205.00 and gave the company an “overweight” rating in a research note on Wednesday. Finally, Piper Sandler boosted their target price on shares of Masimo from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Wednesday. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $194.80.

Masimo Stock Performance

MASI stock opened at $188.77 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The business has a 50-day moving average price of $173.28 and a 200 day moving average price of $153.33. The company has a market capitalization of $10.11 billion, a P/E ratio of 130.19 and a beta of 1.02. Masimo Co. has a 1-year low of $101.61 and a 1-year high of $192.62.

Masimo (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.38. The firm had revenue of $600.70 million during the quarter, compared to the consensus estimate of $593.35 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. As a group, equities research analysts forecast that Masimo Co. will post 4.1 EPS for the current fiscal year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.